Humankind Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
32,606
+6,632
| +26% | +$307K | 0.37% | 39 |
|
|
2025
Q1 | $1.58M | Buy |
25,974
+823
| +3% | +$50.2K | 0.41% | 37 |
|
|
2024
Q4 | $1.42M | Sell |
25,151
-2,297
| -8% | -$130K | 0.36% | 37 |
|
|
2024
Q3 | $1.42M | Sell |
27,448
-1,722
| -6% | -$89.1K | 0.51% | 36 |
|
|
2024
Q2 | $1.21M | Buy |
29,170
+1,431
| +5% | +$59.4K | 0.32% | 48 |
|
|
2024
Q1 | $1.5M | Buy |
27,739
+3,093
| +13% | +$168K | 0.4% | 36 |
|
|
2023
Q4 | $1.26M | Buy |
24,646
+4,403
| +22% | +$226K | 0.38% | 37 |
|
|
2023
Q3 | $1.17M | Buy |
20,243
+991
| +5% | +$57.5K | 0.49% | 28 |
|
|
2023
Q2 | $1.23M | Sell |
19,252
-8,695
| -31% | -$556K | 0.48% | 28 |
|
|
2023
Q1 | $1.94M | Buy |
27,947
+2,371
| +9% | +$164K | 0.8% | 19 |
|
|
2022
Q4 | $1.84M | Sell |
25,576
-747
| -3% | -$53.7K | 0.8% | 21 |
|
|
2022
Q3 | $1.87M | Buy |
26,323
+4,760
| +22% | +$338K | 0.9% | 19 |
|
|
2022
Q2 | $1.66M | Sell |
21,563
-624
| -3% | -$48K | 0.79% | 20 |
|
|
2022
Q1 | $1.62M | Sell |
22,187
-2,556
| -10% | -$187K | 0.66% | 23 |
|
|
2021
Q4 | $1.54M | Buy |
24,743
+6,071
| +33% | +$379K | 1.94% | 12 |
|
|
2021
Q3 | $1.11M | Buy |
18,672
+1,441
| +8% | +$85.3K | 1.68% | 15 |
|
|
2021
Q2 | $1.15M | Buy |
17,231
+6,243
| +57% | +$417K | 2.05% | 12 |
|
|
2021
Q1 | $694K | Buy |
+10,988
| New | +$694K | 2.13% | 15 |
|